Avidity Partners Management as of March 31, 2020
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 50 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Seattle Genetics | 11.1 | $81M | 698k | 115.38 | |
| Merck & Co (MRK) | 5.2 | $38M | 492k | 76.94 | |
| Abbvie (ABBV) | 5.0 | $36M | 477k | 76.19 | |
| McKesson Corporation (MCK) | 4.5 | $33M | 243k | 135.26 | |
| BioMarin Pharmaceutical (BMRN) | 3.5 | $26M | 302k | 84.50 | |
| Regeneron Pharmaceuticals (REGN) | 3.4 | $24M | 50k | 488.30 | |
| Cardinal Health (CAH) | 3.3 | $24M | 505k | 47.94 | |
| Mirati Therapeutics | 3.1 | $23M | 295k | 76.87 | |
| Catalent (CTLT) | 3.0 | $21M | 411k | 51.95 | |
| Momenta Pharmaceuticals | 2.9 | $21M | 780k | 27.20 | |
| Biogen Idec (BIIB) | 2.7 | $20M | 62k | 316.39 | |
| Exelixis (EXEL) | 2.6 | $19M | 1.1M | 17.22 | |
| Biohaven Pharmaceutical Holding | 2.5 | $18M | 540k | 34.03 | |
| Alector (ALEC) | 2.4 | $17M | 714k | 24.13 | |
| Aurinia Pharmaceuticals (AUPH) | 2.4 | $17M | 1.2M | 14.51 | |
| CVS Caremark Corporation (CVS) | 2.3 | $16M | 277k | 59.33 | |
| ACADIA Pharmaceuticals (ACAD) | 2.1 | $15M | 357k | 42.25 | |
| Gilead Sciences (GILD) | 2.1 | $15M | 200k | 74.76 | |
| Acceleron Pharma | 2.1 | $15M | 166k | 89.87 | |
| Alexion Pharmaceuticals | 2.0 | $14M | 160k | 89.79 | |
| Dynavax Technologies (DVAX) | 1.9 | $14M | 3.8M | 3.53 | |
| Kadmon Hldgs | 1.6 | $12M | 2.8M | 4.19 | |
| Axsome Therapeutics (AXSM) | 1.6 | $12M | 197k | 58.83 | |
| Cigna Corp (CI) | 1.6 | $12M | 65k | 177.18 | |
| Uniqure Nv (QURE) | 1.6 | $11M | 237k | 47.45 | |
| Moderna (MRNA) | 1.5 | $11M | 365k | 29.95 | |
| Humana (HUM) | 1.4 | $10M | 33k | 314.03 | |
| Horizon Therapeutics | 1.4 | $9.9M | 333k | 29.62 | |
| Chemocentryx | 1.3 | $9.5M | 236k | 40.18 | |
| Minerva Neurosciences | 1.2 | $8.6M | 1.4M | 6.02 | |
| Neurocrine Biosciences (NBIX) | 1.2 | $8.5M | 98k | 86.55 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $8.1M | 34k | 237.94 | |
| Sarepta Therapeutics (SRPT) | 1.1 | $7.8M | 80k | 97.83 | |
| Ligand Pharmaceuticals In (LGND) | 1.0 | $7.4M | 102k | 72.72 | |
| Ironwood Pharmaceuticals (IRWD) | 1.0 | $7.4M | 735k | 10.09 | |
| Verastem | 1.0 | $7.4M | 2.8M | 2.64 | |
| Charles River Laboratories (CRL) | 1.0 | $7.2M | 57k | 126.21 | |
| Allergan | 1.0 | $7.1M | 40k | 177.10 | |
| Aerie Pharmaceuticals | 0.9 | $6.8M | 507k | 13.50 | |
| Ascendis Pharma A S (ASND) | 0.9 | $6.8M | 60k | 112.62 | |
| Immunomedics | 0.9 | $6.6M | 493k | 13.48 | |
| Amarin Corporation (AMRN) | 0.9 | $6.5M | 1.6M | 4.00 | |
| Esperion Therapeutics (ESPR) | 0.9 | $6.5M | 205k | 31.53 | |
| Coherus Biosciences (CHRS) | 0.9 | $6.2M | 382k | 16.22 | |
| Aimmune Therapeutics | 0.8 | $5.9M | 408k | 14.42 | |
| Anika Therapeutics (ANIK) | 0.7 | $4.9M | 168k | 28.91 | |
| Bioxcel Therapeutics (BTAI) | 0.7 | $4.7M | 211k | 22.35 | |
| Flamel Technologies Sa (AVDL) | 0.4 | $3.0M | 382k | 7.94 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $1.8M | 4.3M | 0.41 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.0 | $278k | 17k | 16.35 |
